BIEIPremier Biomedical Inc

About Premier Biomedical Inc (BIEI)

Premier Biomedical Inc (BIEI) is a Drug Manufacturers - Specialty & Generic company headquartered in El Centro, CA, United States whose shares trade over-the-counter on the Pink tier.

Premier Graphene Inc. is engaged in high-grade graphene production and manufacturing of graphene-enhanced products. Its principal focus, currently, is state of the art new generation ballistic gear. With our team of excellent scientists and collaborators, we have commenced our advancements in these new and exciting endeavors towards a more sustainable future. We expect to be one of the leading companies in our field and a huge aid to the western world's defense, aerospace and green energy sectors. These initiatives have been funded by a public charity, qualified under Internal Revenue Code Section 501(c)(3). We aim to become the production and manufacturing leader in the western world for this very important strategic resource. Graphene is the hardest, most durable, substance known to mankind. It is harder than diamonds. Graphene is also lightweight, thus rendering garments far more comfortable than goods manufactured with other resources. Finally, graphene is super-transmissible. We intend to manufacture products which harness these unique features. Uniquely suited for our graphene, are electronic vehicle batteries, making the cost of such vehicles drastically reduced, up to a 90% cost reduction (especially given the consequent weight reduction). When equipped with graphene, they are also far more durable and the operations far less expensive.

Products and services

Hemp-based initiative, developing graphene-enhanced formulations for a myriad of commercial and military applications.

BIEI key facts

Ticker symbol

BIEI

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

El Centro, CA, United States

Country of incorporation

US

Year of incorporation

2010

Employees

4

Estimated market cap

$599.4K (as of Apr 11, 2025)

Shares outstanding

1,198,879,075

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Quarterly Report (Sep 30, 2024)

Premier Biomedical Inc leadership

• Ivan Mendez — CEO
• William Tynan — Accountant

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with B